Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cited by (1,000)

Items 901–1,000 of 1,000

1. Discovery of new 4-aminoquinoline derivatives containing an amine or hydroxamic acid terminal as multifunctional agents for the treatment of Alzheimer’s disease
   Bochao Zhai, Qianyun Hao, Wang Ming-fan, Zhiqiang Luo, Rui Yun Yang, Jian Tao Yang, Yuqing Cao · 2024 · Bioorganic Chemistry
2. Expanding the Multipotent Profile of Huprine-Tacrine Heterodimers as Disease-Modifying Anti-Alzheimer Agents
   Diego Muñoz‐Torrero, Marta Pera, Júlia Relat, Míriam Ratia, Carles Galdeano, Elisabet Viayna, Irene Sola, Xavier Formosa, Pelayo Camps, Albert Badı́a et al. · 2012 · Neurodegenerative Diseases
3. Neuroprotective role of herbal alternatives in circumventing Alzheimer’s disease through multi-targeting approach - a review
   Sunil K. Ravi, Balenahalli Narasingappa Ramesh, Shilpa Kj, Jagadeesha Poyya, Jyothsna Karanth, Narayanappa Govinda Raju, Chandrashekhar G. Joshi · 2022 · Egyptian Journal of Basic and Applied Sciences
4. The multitarget approach as a green tool in medicinal chemistry
   Rita Bernadett Vlocskó, Sinem Apaydın, Béla Török, Marianna Török · 2022 · Elsevier eBooks
5. Blood–brain barrier permeable benzylpiperidin‐4‐yl‐linked benzylamino benzamides as dual cholinesterase inhibitors
   Razia Banoo, Vijay Kumar Nuthakki, Mohd Abdullaha, Mohit R. Sharma, Sandip Bibishan Bharate · 2022 · Drug Development Research
6. Tackling Neuroinflammation in Cognitive Disorders with Single-targeted and Multi-targeted Histamine H3 Receptor Modulators
   Flávia Barrio Lopes, João Paulo S. Fernandes, Elisa Uliassi · 2024 · Current Topics in Medicinal Chemistry
7. Hybrid Molecules Synergistically Acting Against Protein Aggregation Diseases
   Carsten Korth, Ralf Klingenstein, Andreas Müller‐Schiffmann · 2013 · Current Topics in Medicinal Chemistry
8. Redoubling the ring size of an endomorphin‐2 analog transforms a centrally acting mu‐opioid receptor agonist into a pure peripheral analgesic
   Justyna Piekielna‐Ciesielska, Rossella De Marco, Luca Gentilucci, Maria Camilla Cerlesi, Girolamo Calò, Csaba Tömböly, Roberto Artali, Anna Ewa Janecka · 2016 · Biopolymers
9. 3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects
   Yundong Xie, Ji-Ping Liu, Wei Wang, Yongheng Shi, Xiaoping Wang, Meng Sun, Xinya Xu, Na Li · 2020 · Bioorganic & Medicinal Chemistry Letters
10. Design and Synthesis of Ranitidine Analogs as Multi-Target Directed Ligands for the Treatment of Alzheimer’s Disease
    Jie Gao, Chen Suo, Jui‐Heng Tseng, Melissa A. Moss, Alvin V. Terry, James Chapman · 2021 · International Journal of Molecular Sciences
11. Huprines — an insight into the synthesis and biological properties
    Eva Mezeiová, Ondřej Soukup, Jan Korábečný · 2020 · Russian Chemical Reviews
12. Computational Methods in Multitarget Drug Discovery
    Giovanni Bottegoni, Andrea Cavalli · 2017 · Elsevier eBooks
13. Multiple Ligands in Neurodegenerative Diseases
    Julien Lalut, Christophe Rochais, Patrick Dallemagne · 2017 · Methods and principles in medicinal chemistry
14. Synthesis of Anti‐Alzheimer Molecules: Bridging Chemical Approaches to Pharmaceuticals
    Hasan Abbas, Fatima Noor, Shehla Khalid, Matloob Ahmad, Nasır Rasool, Ayesha Ikram Malik, Muhammad Imran · 2025 · ChemistrySelect
15. Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer’s disease
    A. Meden, Neža Žnidaršič, Damijan Knez, Yuanyuan Wang, Ziwei Xu, Huajing Yang, Weiting Zhang, Anja Hafner Pišlar, Andrej Perdih, Simona Kranjc et al. · 2025 · Acta Pharmaceutica Sinica B
16. Multi‐Target‐Directed Ligands ( MTDLs ) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease
    Jaewoon Jung, Yebeen Kim, Asifiwe Clarisse Cirunduzi, Seonghyun Yoon, Seokyoung Bang, Seung‐Hoon Yang · 2026 · CNS Neuroscience & Therapeutics
17. An Overview of Tetramethylpyrazine (Ligustrazine) and its Derivatives as Potent Anti-Alzheimer’s Disease Agents
    Syed Nasir Abbas Bukhari, Ruchika Yogesh · 2022 · Letters in Drug Design & Discovery
18. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer’s Disease
    Xiuyuan Wu, Xiaotong Ze, Shuai Qin, Beiyu Zhang, Xinnan Li, Qi Gong, Haiyan Zhang, Zheying Zhu, Jinyi Xu · 2024 · Molecules
19. Phytoactive drugs used in the treatment of Alzheimer’s disease and dementia
    Anshita Gupta Soni, Astha Verma, Renjil Joshi, Kamal Shah, Deependra Soni, Chanchal Deep Kaur, Swarnlata Saraf, Nagendra Singh Chauhan · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
20. Neuroprotective Assessment of Nutraceutical (Betanin) in Neuroblastoma Cell Line SHSY-5Y: An in-Vitro and in-Silico Approach
    Natarajan Kiruthiga, Rajkuberan Chandrasekaran, Sundararaj Rajamanikandan, John Joseph, Kalaiselvi Aasaithambi · 2024 · Neurochemical Research
21. Multipotent Effect of Clozapine on Lipopolysaccharide-Induced Acetylcholinesterase, Cyclooxygenase-2,5-Lipoxygenase, and Caspase-3: In Vivo and Molecular Modeling Studies
    Minhajul Arfeen, Devendra Kumar Dhaked, Vasudevan Mani · 2025 · Molecules
22. Comparative studies via in vitro anti-Alzheimer of thiazolidinone based chalcone derivatives: Insight into the synthesis, molecular docking and ADME analysis
    Urooj Jamal, Shoaib Ahmed Khan, Tayyiaba Iqbal, Fazal Rahim, Rafaqat Hussain, Yousaf Khan, Hany W. Darwish · 2025 · Journal of Molecular Structure
23. A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer’s disease
    David R. Greeley, Marshall Nash, Brad Herskowitz, Fred Kim, James Rock, Neils Prins, SangYun Kim, Tianyang Xi, Jonathan A. Busam, Benoit Tete et al. · 2025 · The Journal of Prevention of Alzheimer s Disease
24. Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy
    Cédric Lecoutey, Rémi Legay, Audrey Davis, Jana Sopková‐de Oliveira Santos, Patrick Dallemagne, Christophe Rochais · 2021 · Molecules
25. Unveiling the potential of novel indol-3-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors: a combined in silico , synthesis and in vitro study
    Amit Sharma, Santosh Rudrawar, Ankita Sharma, Sandip Bibishan Bharate, Hemant R. Jadhav · 2024 · RSC Advances
26. Synthesis and biological evaluation of novel AM80 derivatives as antileukemic agents
    Haiyong Bian, Jinhong Feng, Wenfang Xu · 2012 · Medicinal Chemistry Research
27. Multifunctional Enzyme Inhibition for Neuroprotection - A Focus on MAO, NOS, and AChE Inhibitors
    Jacques Joubert, Jacobus Petrus Petzer, Louis H.A. Prins, Benjamin P. Repsold, Sarel F. Malan · 2014 · Elsevier eBooks
28. Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation
    Rita Maria Concetta Di Martino, Giovanni Bottegoni, Francesca Seghetti, Debora Russo, Ilaria Penna, Alessio De Simone, Giuliana Ottonello, Sine Mandrup Bertozzi, Andrea Armirotti, Tiziano Bandiera et al. · 2020 · ChemMedChem
29. Multi-Target-Directed Ligands in Alzheimer’s Disease Therapy
    Eugenie Nepovimová, Kamil Kuča · 2020 · IntechOpen eBooks
30. Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma
    Filipe G. A. Estrada, Silvia Miccoli, Natália Aniceto, Alfonso T. García‐Sosa, Rita Cardoso Guedes · 2021 · Molecules
31. Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy
    Imen Dakhlaoui, Emna Maalej, Hélène Martin, Aurélia Lucht, Isabel Iriepa, Ignacio Moraleda, Jose Luis Marco, Fakher Chabchoub, Lhassane Ismaïli · 2021 · ChemistrySelect
32. Umbelliferyloxymethyl phosphonate compounds-weakly binding zinc ionophores with neuroprotective properties
    Sébastien Guesné, Laura Connole, Stephanie Kim, Majid Motevalli, Lesley G. Robson, Adina Teodora Michael-Titus, Alice C. Sullivan · 2021 · Dalton Transactions
33. Molecular Modeling Techniques Applied to the Design of Multitarget Drugs: Methods and Applications
    Larissa Henriques Evangelista Castro, Carlos Maurício R. Sant’Anna · 2021 · Current Topics in Medicinal Chemistry
34. From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis
    Vanesa Nozal, Alfonso García‐Rubia, Eva P. Cuevas, Concepción Pérez, Carlota Tosat‐Bitrián, Fernando Benito Bartolomé, Eva Carro, David Ramírez, Valle Palomo, Ana Martı́nez · 2021 · Angewandte Chemie
35. Copper and neurodegenerative disorders: potential drugs for possible successful treatment
    Ana Martı́nez, Rubicelia Vargas, Sara E. Pérez-Figueroa, Estrella Ramos · 2021 · Theoretical Chemistry Accounts
36. Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1 H )-one iron chelators in an in vitro cell model of Parkinson's disease
    Frank W. Lewis, Kathleen Bird, Jean-Philippe Navarro, Rawa El Fallah, Jérémy Brandel, Véronique Hubscher‐Bruder, Andrew Tsatsanis, James A. Duce, David Tétard, Samuel Bourne et al. · 2022 · Dalton Transactions
37. Competitive Intelligence–based Lead Generation and Fast Follower Approaches
    Yu You Jiang, Ziping Liu, Jörg Holenz, Hua Dong Yang · 2016 · Methods and principles in medicinal chemistry
38. Latest Progress in the Development of Multitarget Ligands for Alzheimer's Disease Based on the Hantzsch Reaction
    Lhassane Ismaïli, Paul J. Bernard, Bernard Refouvelet · 2022 · Future Medicinal Chemistry
39. Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy
    Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou, Guocan Yu, Xiaoyuan Shawn Chen, Sheng Wang · 2025 · Angewandte Chemie
40. Exploring the multifunctional potential of designed benzothiazole hydrazones
    Riccardo Barbari, Vera Bruggink, Robert Klaus Hofstetter, Chiara Tupini, Leonardo Montani, Sofia Fagnani, Filippo Marchetti, Elisa Durini, Ilaria Lampronti, Silvia Vertuani et al. · 2025 · Biomedicine & Pharmacotherapy
41. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β
    Magham Sai Varshini, Ramakkamma Aishwarya Reddy, Praveen Thaggikuppe Krishnamurthy, Divakar Selvaraj · 2023 · Current Computer - Aided Drug Design
42. Sertraline as a Multi-Target Modulator of AChE, COX-2, BACE-1, and GSK-3β: Computational and In Vivo Studies
    Minhajul Arfeen, Vasudevan Mani · 2024 · Molecules
43. Design, synthesis, and evaluation of benzylpiperidine-derived hydrazones as dual inhibitors of monoamine oxidases and acetylcholinesterase
    Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi · 2024 · Medicinal Chemistry Research
44. Design, synthesis, and activity evaluation of novel multitargeted l ‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease
    Xianghao Zeng, Shaobing Cheng, Huilan Li, Haiyang Yu, Yushun Cui, Yuanying Fang, Shilin Yang, Yulin Feng · 2024 · Archiv der Pharmazie
45. Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite
    Huabin Hu, Carmen Serra, Wenjie Zhang, Aurora Scrivo, Irene Fernández‐Carasa, Antonella Consiglio, Àlvaro Aytés, Miguel Ángel Pujana, Amadeu Llebaria, Albert A. Antolín · 2024 · Cell chemical biology
46. Targeting Lewy body dementia with neflamapimod‐rasagiline hybrids
    Claudia Albertini, Sabrina Petralla, Francesca Massenzio, Barbara Monti, Nicola Rizzardi, Christian Bergamini, Elisa Uliassi, Fernanda Borges, Daniel Chavarria, Gert Fricker et al. · 2024 · Archiv der Pharmazie
47. Recent Molecular Targets and their Ligands for the Treatment of Alzheimer Disease
    Gülşah Bayraktar, Vildan Alptüzün · 2024 · Current Topics in Medicinal Chemistry
48. Intrathecal administration of MCRT produced potent antinociception in chronic inflammatory pain models via μ-δ heterodimer with limited side effects
    Yaofeng Zhao, Zhonghua Zhang, Dingnian Gou, Pengtao Li, Tong Yang, Zhanyu Niu, Jerine Peter Simon, Xuyan Guan, Xinyu Li, Chunbo He et al. · 2024 · Biomedicine & Pharmacotherapy
49. Synthesis and Biological Activity Assessment of 2-Styrylbenzothiazoles as Potential Multifunctional Therapeutic Agents
    Riccardo Barbari, Vera Bruggink, Robert Klaus Hofstetter, Chiara Tupini, Sofia Fagnani, Erika Baldini, Elisa Durini, Ilaria Lampronti, Silvia Vertuani, Anna Baldisserotto et al. · 2024 · Antioxidants
50. Synthesis, DFT, ADMET and molecular docking studies of thiazole derived thiazolidinone-based chalcone derivatives: alzheimer’s disease current therapies
    Muhammad Shahid Nadeem, Jalaluddin Azam Khan, Imran Ahmed Kazmi, Ehssan H. O. Moglad, Muhammad Afzal, Sami Ibrahim Alzarea, Fazal Rahim, Shoaib Ahmed Khan, Khushi Muhammad, Gaurav Gupta · 2024 · Future Medicinal Chemistry
51. Pathway-based network medicine identifies novel natural products for Alzheimer’s disease
    Yumei Liang, Siqi Xie, Jianping Jia · 2025 · Alzheimer s Research & Therapy
52. Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of Alzheimer's disease
    Francesca Mancini, María Laura Bolognesi, Carlo Melchiorre, Vincenza Andrisano · 2009 · Journal of Pharmaceutical and Biomedical Analysis
53. Evaluation on the Quality of Research Field with Traditional Herbal Prescriptions for Dementia Therapy
    Eun-Jung Heo, Jong-Seok Kang, Hyung-Won Kang, Woo-Seok Jeon · 2012 · Journal of Oriental Neuropsychiatry
54. Miscellaneous biological activity profile of imidazole-based compounds: An aspirational goal for medicinal chemistry
    Nusrat Sahiba, Pankaj Teli, Dinesh Kr. Agarwal, Shikha Agarwal · 2022 · Elsevier eBooks
55. 11,12-Diacetyl-carnosol Protects SH-SY5Y Cells from Hydrogen Peroxide Damage through the Nrf2/HO-1 Pathway
    Qingyi Luo, Weiyan Hu, Hao-Fei Yu, Rongping Zhang, Xinglong Chen · 2022 · Evidence-based Complementary and Alternative Medicine
56. Hybridization of amantadine with gardenamide A enhances NMDA antagonism and in vivo anti-PD effects
    Wenda Zhu, Yiping Fan, Yanbing Li, Lizhi Peng, Yi-Fang Li, Fengxia Yan, Jiaqiang Zhao, Lei Zhang, Hiroshi Kurihara, Rong‐Rong He et al. · 2022 · Bioorganic Chemistry
57. Cholinesterase Inhibitory Activity, Kinetic and Molecular Docking Studies of N-(1-substituted-1H-1,2,3-triazole-4-yl)-aralkylamide Derivatives
    Woralak Petrat, Chatchai Wattanapiromsakul, Teerapat Nualnoi, Nadia Hanim Sabri, Vannajan Sanghiran Lee, Luelak Lomlim · 2016 · Walailak Journal of Science and Technology (WJST)
58. Computational Methods for Multi-Target Drug Designing Against Mycobacterium tuberculosis
    Gaurava Srivastava, Ashish Tiwari, Ashok Kumar Sharma · 2018 · Methods in pharmacology and toxicology
59. Vitamine D et maladie d’Alzheimer : d’une curieuse idée à une possibilité de traitement
    Cédric Annweiler · 2014 · Biologie Aujourd hui
60. Discovery and Characterization of Novel Naphthalimide Analogs as Potent Multitargeted Directed Ligands against Alzheimer's Disease
    Jie Gao, James Chapman · 2020 · Drug Development Research
61. Multitarget Drugs for Stabilization of Calcium Cycling and Neuroprotection in Neurodegenerative Diseases and Stroke
    Antonio M. G. de Diego, Silvia Lorrio, Jesús Miguel Hernández-Guijo, Luis Gandı́a, Antonio M. G. de Diego · 2012 · Wiley eBooks
62. Merged Multiple Ligands
    Hongming Chen, Udo Bauer, Ola Engkvist · 2017 · Methods and principles in medicinal chemistry
63. Investigation of the Mechanisms of Neuroprotection Mediated by Lobelia Species via Computational Network Pharmacology and Molecular Modeling
    Qinfang Zheng, Liang-zi Fang, Xiaolong Huang, Ye Wang, Shuihan Zhang · 2020 · Research Square
64. A randomized, controlled, two-center preclinical trial assessing the efficacy of a new benzodiazepine–dihydropyridine hybrid molecule (JM-20) in rodent models of ischemic stroke
    Jeney Ramírez-Sánchez, André Rex, Sarah McCann, Daniel Schulze, Maylin Wong-Guerra, Luis Arturo Fonseca-Fonseca, Enrique García-Alfonso, Ailín Ramírez-Abreu, Ricardo Limonta, Monika Dopatka et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
65. Multicomponent Synthesis of Multi-Target Quinazolines Modulating Cholinesterase, Oxidative Stress, and Amyloid Aggregation Activities for the Therapy of Alzheimer’s Disease
    Saida Chakhari, Jose Luis Marco, Isabel Iriepa, M. Carmo Carreiras, Fakher Chabchoub, Lhassane Ismaïli, Bernard Refouvelet · 2025 · Molecules
66. Novel bis-Thiazolidinone -based chalcones with pyridine linker: Eco-friendly synthesis, cholinesterase and beta-amyloid inhibition potency, and molecular docking studies
    Sobhi M. Gomha, Sami A. Al‐Hussain, Sayed Mohamed Riyadh, Basant Farag, Tariq Z. Abolibda, Marwan M. Alrehaili, Hafsah M. Alakhdhari, Magdi E. A. Zaki · 2025 · Bioorganic Chemistry
67. Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
    Gozde Sayar, Sülünay Parlar, Ayse Hande Tarikogullari, Mümin Alper Erdoğan, Güliz Armağan, Vildan Alptüzün · 2026 · Chemical Biology & Drug Design
68. Parkinson's disease
    Trisha Bhatt, Bhoomika M. Patel, Mayur Mahendrakumar Patel · 2020 · Elsevier eBooks
69. Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease
    Jyoti Pandey · 2023 · Springer eBooks
70. Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents
    Samuele Maramai, M. Saletti, Marco Paolino, Germano Giuliani, Jessica Cazzola, Paolo Spaiardi, Francesca Talpo, Maria Frosini, Alice Pifferi, Marco Ballarotto et al. · 2024 · Bioorganic & Medicinal Chemistry
71. 2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting
    Maria Luisa Di Paolo, Silvia Salerno, Giulia Nordio, Francesco Piazzola, Stefania Sarno, Giuliana Sarno, Benito Natale, Valeria Poggetti, Antonella Borreca, Emma Baglini et al. · 2025 · European Journal of Medicinal Chemistry
72. Unraveling Neurodegenerative Disorders: The Potential of Indole and Imidazole-Based Heterocycles
    Riya Shikha, Deepak Kumar, Mohd Qasid Lari, Astik Manju Ashesh, Pranay Wal, Bhupendra Singh, Shailendra Pandey, Dileep Kumar, Ajay Kumar · 2025 · Current Topics in Medicinal Chemistry
73. Recent Advances in the Quest for Treatment and Management of Alzheimer and Other Dementia
    Sameena Ejaz Tanwir, Ajay Kumar · 2019 · Open Journal of Medicinal Chemistry
74. Mısır İpeği’nin (Zea Mays L.) Antioksidan ve Antiradikal Özelliklerinin Belirlenmesi
    Leyla Polat Köse · 2021 · Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi
75. Computational design of new tacrine analogs: an in silico prediction of their cholinesterase inhibitory, antioxidant, and hepatotoxic activities
    Selsabil Djafarou, Imene Amine Khodja, H. Boulebd · 2021 · Journal of Biomolecular Structure and Dynamics
76. Design, synthesis and anticholinergic properties of novel α-benzyl dopamine, tyramine, and phenethylamine derivatives
    Ali Naderi, Akın Akıncıoğlu, Ahmet Çağan, Hilal Çelikkaleli, Hülya Akıncıoğlu, Süleyman Göksu · 2024 · Bioorganic Chemistry
77. In silico molecular modeling and in vitro biological screening of novel benzimidazole-based piperazine derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors
    Haseena Naz, Fazal Rahim, Rafaqat Hussain, Shoaib Ahmed Khan, Wajid Ur Rehman, Yousaf Khan, Tariq A. Aziz, Metab Alharbi · 2024 · Zeitschrift für Naturforschung C
78. Synthesis, In vitro biological evaluation and molecular modeling study of thiadiazole-sulphonamide hybrid derivatives as potential anti-Alzheimer agents
    Javed Khan, Hayat Ullah, Shawkat Hayat, Shahzad Ahmad Abbasi, Asmat Bibi, Kainat Bibi, Muhammad Nabi, Muhammad Saleem Khan, Lala Gurbanova, Kasim Sakran Abass · 2025 · Chemical Data Collections
79. Computational evidence to design an appropriate candidate for the treatment of Alzheimer's disease through replacement of the heptamethylene linker of bis(7)tacrine with S-allylcysteine
    Mahboobeh Eslami, Seyed Majid Hashemianzadeh, Kiana Gholamjani Moghaddam, Layasadat Khorsandi, Seyed Abolfazl Seyed Sajadi · 2015 · RSC Advances
80. Bioinorganic Neurochemistry
    Drew S. Folk, Filip Kielar, Katherine J. Franz · 2013 · Elsevier eBooks
81. Knowledgebase for addiction-related genes: Is it possible an extrapolation to rational multi-target drug design?
    Michel Espinoza-Fonseca · 2008 · Bioorganic & Medicinal Chemistry
82. Medicinal Chemistry and Ligand Profiling for Evaluation of Promising Marine Bioactive Molecules
    Anna K. Croft, Wilma Groenewald, Michelle S. Tierney · 2011 · Springer eBooks
83. Discovery of Multi-Target Agents for Neurological Diseases via Ligand Design
    María Laura Bolognesi, Carlo Melchiorre, Cornelis J. Van der Schyf, Moussa B. H. Youdim · 2012 · Royal Society of Chemistry eBooks
84. Special Issue: “Molecules against Alzheimer”
    Michael W. Decker, Diego Muñoz‐Torrero · 2016 · Molecules
85. Chlorophenols in organic synthesis
    V. V. Mitin, Ekaterina A. Ivanova, Полина Евгеньевна Прохорова, Yu. Yu. Morzherin · 2016 · Chimica Techno Acta
86. Case studies on computer-based identification of natural products as lead molecules
    Conrad Veranso Simoben, Fidele Ntie‐Kang, Dina Robaa, Wolfgang Sippl · 2020 · Physical Sciences Reviews
87. Synthesis and Activity of Miconazole Derivatives as Dual BChE/IDO1 Inhibitors for the Treatment of Alzheimer's Disease
    Xin Lü, Yijun Liu, Nan Qin, Hongyu Yang, Yuting Qiao, Xueyang Jiang, Yao Chen, Feng Feng, Wenyuan Liu, You Zhou et al. · 2021 · Future Medicinal Chemistry
88. Discovery of potent dual ligands for dopamine D4 and σ1 receptors
    Nicolas Levoin, Appala Venkata Ramana Murthy, Vennu Narendar, Nangunoori Sampath Kumar, Pasula Aparna, Anagani Kanaka Durga Bhavani, Chada Raji Reddy, Paul Mosset, Rene L. Gree · 2022 · Bioorganic & Medicinal Chemistry
89. Advanced Chemometric Modeling Approaches for the Design of Multitarget Drugs Against Neurodegenerative Diseases
    Amit Kumar Halder, Ana S. Moura, M. Natália D. S. Cordeiro · 2018 · Methods in pharmacology and toxicology
90. Anti-Acetylcholinesterase Derivatives: A Privileged Structural Framework in Drug Discovery to Treat Alzheimer’s Disease
    Monika Bhardwaj, Vaishali Manikrao Patil, Rakhi Dhiman, Satya P. Gupta, Neeraj Masand · 2019 · Current Enzyme Inhibition
91. Polypharmacology in Drug Discovery
    Oscar Méndez‐Lucio, J. Jesús Naveja, Hugo Vite‐Caritino, Fernando Daniel Prieto-Martínez, José L. Medina‐Franco · 2017 · Methods and principles in medicinal chemistry
92. Multitarget Drug Discovery
    María Laura Bolognesi, Michele Rossi · 2020 · Encyclopedia of Life Sciences
93. N-Degron PROTACs as a Potential Therapeutic Approach for Chronic Myeloid Leukemia
    Grace Hohman, Mohamed A. Eldeeb · 2025 · Anti-Cancer Agents in Medicinal Chemistry
94. Novel chimeric peptides of endomorphin-2 and the active fragments of ghrelin exhibit blood-brain barrier permeability and central antinociceptive effects with reduced opioid-related side effects
    Yongling Liu, Biao Xu, Songxia Cheng, Yan Wang, Jiali Ding, Xiaoyu Shen, Bing Wu, Liangquan Xu, Jie Wei · 2025 · Neuropharmacology
95. Click Chemistry‐Aided Synthesis of Triazole‐Tethered Benzothiazoles as Novel Multifunctional Agents Against Alzheimer's Disease
    Mostafa M. Elbadawi, Abdullah A. Elgazar, Ahmed A. Hefny, Maha‐Hamadien Abdulla, Thamer Bin Traiki, Eslam Roshdy, Mohammad Mahmoud Al-Sanea, Manabu Abe, Wagdy Mohamed Eldehna, Praveen P. N. Rao et al. · 2025 · Archiv der Pharmazie
96. Pyranotacrines as prospective multi-target compounds against Alzheimer's disease
    Salma Fares, Walaa M. El Husseiny, Khalid B. Selim, Mohammed A. M. Massoud · 2025 · Bioorganic & Medicinal Chemistry
97. Design, synthesis, and biological evaluation of kenpaullone derivatives as potential dual inhibitors of cholinesterases and glycogen synthase kinase-3β
    Rinky Raghuvanshi, Satish C Wakudkar, Sudhakar Manda, Sandip Bibishan Bharate · 2025 · Bioorganic Chemistry
98. Targeting Alzheimer's disease via phytochemicals from Artemisia campestris L.: GC/MS analysis with an integrated computational approach
    Nafila Zouaghi, Elhafnaoui Lanez, Mohammed Larbi Benamor, Salah Neghmouche Nacer, Touhami Lanez, Yahia Bekkar, Habiba Haddad, Khairallah Al-Abdallat, Malek Zihlif, Yahya Al-Abdallat et al. · 2025 · Food Bioscience
99. Identification of Potential Multitarget Directed Ligands for Alzheimer’s Disease by Coupling Virtual Screening and Experimental Validation
    Paulina Valenzuela-Hormazábal, Jessica Valero-Rojas, Loreto Martínez‐González, Sandra Ramos-Inza, Victoria Oviedo-Pino, Cristian González-Ortega, Guillermina Hernando, Jhon J. López, Cecilia Scorza, Carolina Echeverry et al. · 2026 · Journal of Chemical Information and Modeling
100. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
     Wen‐Chao Yang, Qi Sun, Ningxi Yu, Xiao‐Lei Zhu, Guang‐Fu Yang · 2012 · PubMed